BPH Mouse Monoclonal Antibody [Clone ID: YPBH-2]

Specifications

Product Data
Clone Name	YPBH-2
Applications	ELISA, IHC
Recommend Dilution	This Benign Prostatic Hyperplasia antibody is suitable for use in ELISA and Immunohistochemistry. It was nor reaction in non-prostate normal tissue, neither prostate malignant tissue positive. This anti-BPH antibody can react with some of well-moderately differential prostate normal tissue and very rarely react with poor differential prostate normal tissue.
Reactivity	Human
Host	Mouse
Clonality	Monoclonal
Immunogen	Highly purified Benign Prostatic Hyperplasia (BPH).
Specificity	Reactive with BPH or Human prostate epithelial cells. Does not react with a variety of Human normal tissues
Formulation	0.01M PBS, pH 7.2 without preservatives. State: Aff - Purified State: Lyophilized purified Ig fraction.
Reconstitution Method	Restore with Double distillated water to adjust the final concentration to 1.0 mg/ml.
Purification	Affinity Chromatography on Protein G.
Conjugation	Unconjugated
Storage Condition	Store the antibody at -20°C. After reconstitution, aliquot and store at -20°C.
Background	Benign prostatic hyperplasia (BPH) is a disease of unknown etiology that significantly affects the quality of life in aging men. Histologic BPH may present itself either as symptomatic or asymptomatic in nature. Benign prostatic hyperplasia (BPH), also known as benign enlargement of the prostate (BEP), is a condition that characterized by an increase in prostate size due to the formation of large nodules in the periurethral region of the prostate. Common in middle-aged and elderly men, benign prostatic hyperplasia leads to an obstruction of the urethra, thus interfering with normal urine flow and causing an urgency to urinate, as well as a decrease in urine flow. In some instances, benign prostatic hyperplasia can lead to recurrent urinary tract infections, bladder stones and kidney failure. These more serious afflictions are a direct result of an increase in the bacterial count within the bladder, a common phenomenon when urine flow is compromised. While mild cases of benign prostatic hyperplasia can be treated by a simple decrease in fluid intake, moderate to severe cases generally require medical treatment in the form of oral drugs or prostate surgery.
Synonyms	Benign Prostatic Hyperplasia
Reference Data

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.